ArticleOncotarget2017

Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics.

Jiao Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.